Just a reminder from the last annual report:-
"Worldwide, it is estimated that patients suffering diabetic, venous and pressure ulcers spent US$14 billion in
2010 on wound dressings, with a compound annual growth rate of 25%(1). World market growth is being driven
by an aging population, an increased incidence of venous disease and diabetes and the increasing afford-ability
of health care in developing countries(2). The potential for consumer, retail and acute wound care products offers
an additional and substantially larger opportunity."
Just a simple math calculation :-
1% of 14billion annually
30% Margin
Gives a profit of 42million.
- Forums
- ASX - By Stock
- TIS
- vitrogro ecm meets ce mark requirements
vitrogro ecm meets ce mark requirements , page-4
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)